Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer or Mild Cognitive Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Not applicableUnknownNCT05004558
What this trial is testing

Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias

Who this might be right for
DementiaAlzheimer DiseaseDementia, Vascular+14 more
Drexel University 36
Large-scale testing (Phase 3)Looking for participantsNCT07752784
What this trial is testing

Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.

Who this might be right for
Alzheimer's Disease
JYAMS PET Research & Development Limited 12
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Testing effectiveness (Phase 2)Looking for participantsNCT07512362
What this trial is testing

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Who this might be right for
Mild Cognitive ImpairmentEarly Alzheimer's DiseaseAD-MCI
Bernard (Barry) Baumel 10
Testing effectiveness (Phase 2)Study completedNCT01518374
What this trial is testing

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Avid Radiopharmaceuticals 1,768
Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Not applicableStudy completedNCT04111211
What this trial is testing

Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits

Who this might be right for
Alzheimer Disease
University Hospital, Bordeaux 1,028
Not applicableStudy completedNCT02843529
What this trial is testing

Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentMemory Disorders+3 more
Altoida 548
Testing effectiveness (Phase 2)Study completedNCT03919669
What this trial is testing

A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 27
Early research (Phase 1)Looking for participantsNCT06786676
What this trial is testing

Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

Who this might be right for
Healthy
Amyloid Solution Inc 88
Early research (Phase 1)Looking for participantsNCT07169630
What this trial is testing

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer s DiseaseMild Cognitive ImpairmentHealthy
National Institute of Mental Health (NIMH) 90
Not applicableUnknownNCT02013518
What this trial is testing

Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia

Who this might be right for
Alzheimers' Disease
Oslo University Hospital 200
Not applicableStudy completedNCT04733989
What this trial is testing

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early OnsetMild Cognitive Impairment+3 more
GAP Innovations, PBC 1,002
Early research (Phase 1)Study completedNCT06774261
What this trial is testing

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Helse Stavanger HF 16
Very early researchNot Yet RecruitingNCT07214974
What this trial is testing

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

Who this might be right for
Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease Dementia+7 more
Noah Tech, Corp. 600
Early research (Phase 1)Ended earlyNCT03819699
What this trial is testing

Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 3
Early research (Phase 1)Study completedNCT02221622
What this trial is testing

Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of Southern California 24
Very early researchActive Not RecruitingNCT04075435
What this trial is testing

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAnxietyAgitation,Psychomotor+1 more
Mclean Hospital 12
Next Page